CLINICAL_TRIALS
trial_result
· 2012-07-10
Clinical Trial Update: IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease [Phase 2]
Summary
Phase 2 trial update showing that the IMA901 study in advanced renal cell carcinoma with measurable disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Immatics Biotechnologies GmbH | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED